Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED95 Dose Exploration of Remimazolam Tosilate for Induction of General Anesthesia in Adults
ChiCTR2100047868Phase 4Not yet recruiting
- Sponsor
- Renmin Hospital of Wuhan University
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam in general anesthesia, sponsored by Renmin Hospital of Wuhan University. Primary endpoint: success rate of sedation. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
general anesthesia
Beyond the preview
Go deeper on ChiCTR2100047868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047868.